Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study
Identifieur interne : 002733 ( Istex/Corpus ); précédent : 002732; suivant : 002734Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study
Auteurs : Thomas M. Painter ; Kassamba L. Diaby ; Danielle M. Matia ; Lillian S. Lin ; Toussaint S. Sibailly ; Moïse K. Kouassi ; Ehounou R. Ekpini ; Thierry H. Roels ; Stefan Z. WiktorSource :
- BMJ [ 0959-8138 ] ; 2004-09-04.
English descriptors
- KwdEn :
- Abidjan, Aids cartoux, Aids conference, Antenatal, Burkina faso, Child transmission, Clinic, Clinical trial, Data collection, Disease control, Global aids program, Individual women, Interview women, Interviewee, Interviewer, Laboratory numbers, Negative experiences, Negative views, Oral zidovudine, Other clinic departments, Other people, Perinatal transmission, Personal factors, Positive test results, Pregnant women, Programme, Programme doctor, Programme level, Programme policies, Programme staff, Programme staff need, Projet, Prophylaxis, Public antenatal clinic, Public health, Purposive recruitment, Randomized trial, Rapid testing, Service delivery, Short course antiretroviral prophylaxis, Social worker, Social workers, Staff members, Test results, Zidovudine.
- Teeft :
- Abidjan, Aids cartoux, Aids conference, Antenatal, Burkina faso, Child transmission, Clinic, Clinical trial, Data collection, Disease control, Global aids program, Individual women, Interview women, Interviewee, Interviewer, Laboratory numbers, Negative experiences, Negative views, Oral zidovudine, Other clinic departments, Other people, Perinatal transmission, Personal factors, Positive test results, Pregnant women, Programme, Programme doctor, Programme level, Programme policies, Programme staff, Programme staff need, Projet, Prophylaxis, Public antenatal clinic, Public health, Purposive recruitment, Randomized trial, Rapid testing, Service delivery, Short course antiretroviral prophylaxis, Social worker, Social workers, Staff members, Test results, Zidovudine.
Abstract
Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Côte d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.
Url:
DOI: 10.1136/bmj.329.7465.543
Links to Exploration step
ISTEX:7880DBA1A34EF8B38B616FD5097E4C522B2BB60ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title><author><name sortKey="Painter, Thomas M" sort="Painter, Thomas M" uniqKey="Painter T" first="Thomas M" last="Painter">Thomas M. Painter</name><affiliation><mods:affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence to: T M Painter</mods:affiliation></affiliation></author><author><name sortKey="Diaby, Kassamba L" sort="Diaby, Kassamba L" uniqKey="Diaby K" first="Kassamba L" last="Diaby">Kassamba L. Diaby</name><affiliation><mods:affiliation>Projet RETRO-CI, US Embassy/CDC-HIV, 01 BP 1712 Abidjan 01, Côte d'Ivoire</mods:affiliation></affiliation></author><author><name sortKey="Matia, Danielle M" sort="Matia, Danielle M" uniqKey="Matia D" first="Danielle M" last="Matia">Danielle M. Matia</name><affiliation><mods:affiliation>266th Pl SE, Sammamish, Washington 98075, USA</mods:affiliation></affiliation></author><author><name sortKey="Lin, Lillian S" sort="Lin, Lillian S" uniqKey="Lin L" first="Lillian S" last="Lin">Lillian S. Lin</name><affiliation><mods:affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</mods:affiliation></affiliation></author><author><name sortKey="Sibailly, Toussaint S" sort="Sibailly, Toussaint S" uniqKey="Sibailly T" first="Toussaint S" last="Sibailly">Toussaint S. Sibailly</name><affiliation><mods:affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</mods:affiliation></affiliation></author><author><name sortKey="Kouassi, Moise K" sort="Kouassi, Moise K" uniqKey="Kouassi M" first="Moïse K" last="Kouassi">Moïse K. Kouassi</name><affiliation><mods:affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</mods:affiliation></affiliation></author><author><name sortKey="Ekpini, Ehounou R" sort="Ekpini, Ehounou R" uniqKey="Ekpini E" first="Ehounou R" last="Ekpini">Ehounou R. Ekpini</name><affiliation><mods:affiliation>Department of HIV/AIDS (Prevention)-Room C-128, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland</mods:affiliation></affiliation></author><author><name sortKey="Roels, Thierry H" sort="Roels, Thierry H" uniqKey="Roels T" first="Thierry H" last="Roels">Thierry H. Roels</name><affiliation><mods:affiliation>Global AIDS Program, BOTUSA Project, PO Box 90, Gaborone, Botswana</mods:affiliation></affiliation></author><author><name sortKey="Wiktor, Stefan Z" sort="Wiktor, Stefan Z" uniqKey="Wiktor S" first="Stefan Z" last="Wiktor">Stefan Z. Wiktor</name><affiliation><mods:affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7880DBA1A34EF8B38B616FD5097E4C522B2BB60E</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1136/bmj.329.7465.543</idno><idno type="url">https://api.istex.fr/document/7880DBA1A34EF8B38B616FD5097E4C522B2BB60E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002733</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002733</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title><author><name sortKey="Painter, Thomas M" sort="Painter, Thomas M" uniqKey="Painter T" first="Thomas M" last="Painter">Thomas M. Painter</name><affiliation><mods:affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence to: T M Painter</mods:affiliation></affiliation></author><author><name sortKey="Diaby, Kassamba L" sort="Diaby, Kassamba L" uniqKey="Diaby K" first="Kassamba L" last="Diaby">Kassamba L. Diaby</name><affiliation><mods:affiliation>Projet RETRO-CI, US Embassy/CDC-HIV, 01 BP 1712 Abidjan 01, Côte d'Ivoire</mods:affiliation></affiliation></author><author><name sortKey="Matia, Danielle M" sort="Matia, Danielle M" uniqKey="Matia D" first="Danielle M" last="Matia">Danielle M. Matia</name><affiliation><mods:affiliation>266th Pl SE, Sammamish, Washington 98075, USA</mods:affiliation></affiliation></author><author><name sortKey="Lin, Lillian S" sort="Lin, Lillian S" uniqKey="Lin L" first="Lillian S" last="Lin">Lillian S. Lin</name><affiliation><mods:affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</mods:affiliation></affiliation></author><author><name sortKey="Sibailly, Toussaint S" sort="Sibailly, Toussaint S" uniqKey="Sibailly T" first="Toussaint S" last="Sibailly">Toussaint S. Sibailly</name><affiliation><mods:affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</mods:affiliation></affiliation></author><author><name sortKey="Kouassi, Moise K" sort="Kouassi, Moise K" uniqKey="Kouassi M" first="Moïse K" last="Kouassi">Moïse K. Kouassi</name><affiliation><mods:affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</mods:affiliation></affiliation></author><author><name sortKey="Ekpini, Ehounou R" sort="Ekpini, Ehounou R" uniqKey="Ekpini E" first="Ehounou R" last="Ekpini">Ehounou R. Ekpini</name><affiliation><mods:affiliation>Department of HIV/AIDS (Prevention)-Room C-128, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland</mods:affiliation></affiliation></author><author><name sortKey="Roels, Thierry H" sort="Roels, Thierry H" uniqKey="Roels T" first="Thierry H" last="Roels">Thierry H. Roels</name><affiliation><mods:affiliation>Global AIDS Program, BOTUSA Project, PO Box 90, Gaborone, Botswana</mods:affiliation></affiliation></author><author><name sortKey="Wiktor, Stefan Z" sort="Wiktor, Stefan Z" uniqKey="Wiktor S" first="Stefan Z" last="Wiktor">Stefan Z. Wiktor</name><affiliation><mods:affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="ISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2004-09-04">2004-09-04</date><biblScope unit="volume">329</biblScope><biblScope unit="issue">7465</biblScope><biblScope unit="page" from="543">543</biblScope></imprint><idno type="ISSN">0959-8138</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-8138</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abidjan</term><term>Aids cartoux</term><term>Aids conference</term><term>Antenatal</term><term>Burkina faso</term><term>Child transmission</term><term>Clinic</term><term>Clinical trial</term><term>Data collection</term><term>Disease control</term><term>Global aids program</term><term>Individual women</term><term>Interview women</term><term>Interviewee</term><term>Interviewer</term><term>Laboratory numbers</term><term>Negative experiences</term><term>Negative views</term><term>Oral zidovudine</term><term>Other clinic departments</term><term>Other people</term><term>Perinatal transmission</term><term>Personal factors</term><term>Positive test results</term><term>Pregnant women</term><term>Programme</term><term>Programme doctor</term><term>Programme level</term><term>Programme policies</term><term>Programme staff</term><term>Programme staff need</term><term>Projet</term><term>Prophylaxis</term><term>Public antenatal clinic</term><term>Public health</term><term>Purposive recruitment</term><term>Randomized trial</term><term>Rapid testing</term><term>Service delivery</term><term>Short course antiretroviral prophylaxis</term><term>Social worker</term><term>Social workers</term><term>Staff members</term><term>Test results</term><term>Zidovudine</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Abidjan</term><term>Aids cartoux</term><term>Aids conference</term><term>Antenatal</term><term>Burkina faso</term><term>Child transmission</term><term>Clinic</term><term>Clinical trial</term><term>Data collection</term><term>Disease control</term><term>Global aids program</term><term>Individual women</term><term>Interview women</term><term>Interviewee</term><term>Interviewer</term><term>Laboratory numbers</term><term>Negative experiences</term><term>Negative views</term><term>Oral zidovudine</term><term>Other clinic departments</term><term>Other people</term><term>Perinatal transmission</term><term>Personal factors</term><term>Positive test results</term><term>Pregnant women</term><term>Programme</term><term>Programme doctor</term><term>Programme level</term><term>Programme policies</term><term>Programme staff</term><term>Programme staff need</term><term>Projet</term><term>Prophylaxis</term><term>Public antenatal clinic</term><term>Public health</term><term>Purposive recruitment</term><term>Randomized trial</term><term>Rapid testing</term><term>Service delivery</term><term>Short course antiretroviral prophylaxis</term><term>Social worker</term><term>Social workers</term><term>Staff members</term><term>Test results</term><term>Zidovudine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Côte d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.</div></front></TEI><istex><corpusName>bmj</corpusName><keywords><teeft><json:string>programme</json:string><json:string>prophylaxis</json:string><json:string>zidovudine</json:string><json:string>programme staff</json:string><json:string>pregnant women</json:string><json:string>positive test results</json:string><json:string>abidjan</json:string><json:string>test results</json:string><json:string>interviewee</json:string><json:string>projet</json:string><json:string>antenatal</json:string><json:string>disease control</json:string><json:string>burkina faso</json:string><json:string>social workers</json:string><json:string>social worker</json:string><json:string>child transmission</json:string><json:string>global aids program</json:string><json:string>aids cartoux</json:string><json:string>public health</json:string><json:string>negative experiences</json:string><json:string>public antenatal clinic</json:string><json:string>individual women</json:string><json:string>short course antiretroviral prophylaxis</json:string><json:string>purposive recruitment</json:string><json:string>programme doctor</json:string><json:string>other clinic departments</json:string><json:string>interview women</json:string><json:string>laboratory numbers</json:string><json:string>aids conference</json:string><json:string>data collection</json:string><json:string>personal factors</json:string><json:string>negative views</json:string><json:string>staff members</json:string><json:string>programme staff need</json:string><json:string>service delivery</json:string><json:string>programme policies</json:string><json:string>other people</json:string><json:string>programme level</json:string><json:string>oral zidovudine</json:string><json:string>randomized trial</json:string><json:string>perinatal transmission</json:string><json:string>rapid testing</json:string><json:string>clinical trial</json:string><json:string>interviewer</json:string><json:string>clinic</json:string></teeft></keywords><author><json:item><name>Thomas M Painter</name><affiliations><json:string>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</json:string><json:string>Correspondence to: T M Painter</json:string></affiliations></json:item><json:item><name>Kassamba L Diaby</name><affiliations><json:string>Projet RETRO-CI, US Embassy/CDC-HIV, 01 BP 1712 Abidjan 01, Côte d'Ivoire</json:string></affiliations></json:item><json:item><name>Danielle M Matia</name><affiliations><json:string>266th Pl SE, Sammamish, Washington 98075, USA</json:string></affiliations></json:item><json:item><name>Lillian S Lin</name><affiliations><json:string>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</json:string></affiliations></json:item><json:item><name>Toussaint S Sibailly</name><affiliations><json:string>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</json:string></affiliations></json:item><json:item><name>Moïse K Kouassi</name><affiliations><json:string>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</json:string></affiliations></json:item><json:item><name>Ehounou R Ekpini</name><affiliations><json:string>Department of HIV/AIDS (Prevention)-Room C-128, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland</json:string></affiliations></json:item><json:item><name>Thierry H Roels</name><affiliations><json:string>Global AIDS Program, BOTUSA Project, PO Box 90, Gaborone, Botswana</json:string></affiliations></json:item><json:item><name>Stefan Z Wiktor</name><affiliations><json:string>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Infectious diseases</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Immunology (including allergy)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Pregnancy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Reproductive medicine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Child health</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Sexual health</value></json:item></subject><articleId><json:string>bmj.329.7465.543</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>research-article</json:string></originalGenre><abstract>Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Côte d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.</abstract><qualityIndicators><score>7.238</score><pdfVersion>1.2</pdfVersion><pdfPageSize>595 x 842 pts (A4)</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>6</keywordCount><abstractCharCount>1749</abstractCharCount><pdfWordCount>4238</pdfWordCount><pdfCharCount>25750</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>256</abstractWordCount></qualityIndicators><title>Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title><pmid><json:string>15345628</json:string></pmid><genre><json:string>research-article</json:string></genre><host><title>BMJ</title><language><json:string>unknown</json:string></language><issn><json:string>0959-8138</json:string></issn><eissn><json:string>1468-5833</json:string></eissn><publisherId><json:string>BMJ</json:string></publisherId><volume>329</volume><issue>7465</issue><pages><first>543</first><total>1</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>general & internal medicine</json:string></scienceMetrix><inist><json:string>sciences humaines et sociales</json:string></inist></categories><publicationDate>2004</publicationDate><copyrightDate>2004</copyrightDate><doi><json:string>10.1136/bmj.329.7465.543</json:string></doi><id>7880DBA1A34EF8B38B616FD5097E4C522B2BB60E</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/7880DBA1A34EF8B38B616FD5097E4C522B2BB60E/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/7880DBA1A34EF8B38B616FD5097E4C522B2BB60E/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/7880DBA1A34EF8B38B616FD5097E4C522B2BB60E/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://publisher-list.data.istex.fr">British Medical Journal Publishing Group</publisher><availability><licence><p>© 2004 BMJ Publishing Group Ltd.</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</p></availability><date>2004-09-02</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Correspondence to: T M Painter</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title><author xml:id="author-0000"><persName><forename type="first">Thomas M</forename><surname>Painter</surname></persName><note type="biography">behavioral scientist</note><affiliation>behavioral scientist</affiliation><affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</affiliation><affiliation>Correspondence to: T M Painter</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Kassamba L</forename><surname>Diaby</surname></persName><note type="biography">medical supervisor</note><affiliation>medical supervisor</affiliation><affiliation>Projet RETRO-CI, US Embassy/CDC-HIV, 01 BP 1712 Abidjan 01, Côte d'Ivoire</affiliation></author><author xml:id="author-0002"><persName><forename type="first">Danielle M</forename><surname>Matia</surname></persName><note type="biography">program officer</note><affiliation>program officer</affiliation><affiliation>266th Pl SE, Sammamish, Washington 98075, USA</affiliation></author><author xml:id="author-0003"><persName><forename type="first">Lillian S</forename><surname>Lin</surname></persName><note type="biography">acting leader, statistics team</note><affiliation>acting leader, statistics team</affiliation><affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</affiliation></author><author xml:id="author-0004"><persName><forename type="first">Toussaint S</forename><surname>Sibailly</surname></persName><note type="biography">technical advisor</note><affiliation>technical advisor</affiliation><affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</affiliation></author><author xml:id="author-0005"><persName><forename type="first">Moïse K</forename><surname>Kouassi</surname></persName><note type="biography">manager, local area network</note><affiliation>manager, local area network</affiliation><affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</affiliation></author><author xml:id="author-0006"><persName><forename type="first">Ehounou R</forename><surname>Ekpini</surname></persName><note type="biography">medical officer</note><affiliation>medical officer</affiliation><affiliation>Department of HIV/AIDS (Prevention)-Room C-128, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland</affiliation></author><author xml:id="author-0007"><persName><forename type="first">Thierry H</forename><surname>Roels</surname></persName><note type="biography">associate director</note><affiliation>associate director</affiliation><affiliation>Global AIDS Program, BOTUSA Project, PO Box 90, Gaborone, Botswana</affiliation></author><author xml:id="author-0008"><persName><forename type="first">Stefan Z</forename><surname>Wiktor</surname></persName><note type="biography">chief, Surveillance and Infrastructure Development Branch, Global AIDS Program</note><affiliation>chief, Surveillance and Infrastructure Development Branch, Global AIDS Program</affiliation><affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</affiliation></author><idno type="istex">7880DBA1A34EF8B38B616FD5097E4C522B2BB60E</idno><idno type="ark">ark:/67375/NVC-RB7R9HHS-X</idno><idno type="DOI">10.1136/bmj.329.7465.543</idno><idno type="href">bmj-329-543.pdf</idno><idno type="article-id">bmj.329.7465.543</idno><idno type="PMID">15345628</idno><idno type="local">bmj;329/7465/543</idno></analytic><monogr><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="pISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><idno type="publisher-id">BMJ</idno><idno type="PublisherID-hwp">bmj</idno><idno type="PublisherID-nlm-ta">BMJ</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2004-09-04"></date><biblScope unit="volume">329</biblScope><biblScope unit="issue">7465</biblScope><biblScope unit="page" from="543">543</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2004-09-02</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Côte d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>hwp-journal-coll</head><item><term>Infectious diseases</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>hwp-journal-coll</head><item><term>Immunology (including allergy)</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>hwp-journal-coll</head><item><term>Pregnancy</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>hwp-journal-coll</head><item><term>Reproductive medicine</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>hwp-journal-coll</head><item><term>Child health</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>hwp-journal-coll</head><item><term>Sexual health</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2004-09-02">Created</change><change when="2004-09-04">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/7880DBA1A34EF8B38B616FD5097E4C522B2BB60E/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="research-article" xml:lang="en"><front><journal-meta><journal-id journal-id-type="hwp">bmj</journal-id><journal-id journal-id-type="nlm-ta">BMJ</journal-id><journal-id journal-id-type="publisher-id">BMJ</journal-id><journal-title>BMJ</journal-title><abbrev-journal-title abbrev-type="publisher">BMJ</abbrev-journal-title><abbrev-journal-title abbrev-type="pubmed">BMJ</abbrev-journal-title><issn pub-type="ppub">0959-8138</issn><issn pub-type="epub">1468-5833</issn><publisher><publisher-name>British Medical Journal Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">bmj.329.7465.543</article-id><article-id pub-id-type="doi">10.1136/bmj.329.7465.543</article-id><article-id pub-id-type="other">bmj;329/7465/543</article-id><article-id pub-id-type="pmid">15345628</article-id><article-id pub-id-type="other">543</article-id><article-id pub-id-type="other">bmj.329.7465.543</article-id><article-categories><subj-group subj-group-type="heading"><subject content-type="original">Papers</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Infectious diseases</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Immunology (including allergy)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Pregnancy</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Reproductive medicine</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Child health</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Sexual health</subject></subj-group></article-categories><title-group><article-title>Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Painter</surname><given-names>Thomas M</given-names></name><role>behavioral scientist</role><email xlink:type="simple">tcp2@cdc.gov</email><xref ref-type="corresp" rid="COR1"></xref><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diaby</surname><given-names>Kassamba L</given-names></name><role>medical supervisor</role><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Matia</surname><given-names>Danielle M</given-names></name><role>program officer</role><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>Lillian S</given-names></name><role>acting leader, statistics team</role><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sibailly</surname><given-names>Toussaint S</given-names></name><role>technical advisor</role><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kouassi</surname><given-names>Moïse K</given-names></name><role>manager, local area network</role><xref ref-type="aff" rid="A5">3</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ekpini</surname><given-names>Ehounou R</given-names></name><role>medical officer</role><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Roels</surname><given-names>Thierry H</given-names></name><role>associate director</role><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wiktor</surname><given-names>Stefan Z</given-names></name><role>chief, Surveillance and Infrastructure Development Branch, Global AIDS Program</role><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label> Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</aff><aff id="A2"><label>2</label> 266th Pl SE, Sammamish, Washington 98075, USA</aff><aff id="A3"><label>3</label> Projet RETRO-CI, US Embassy/CDC-HIV, 01 BP 1712 Abidjan 01, Côte d'Ivoire</aff><aff id="A4"><label>4</label> Department of HIV/AIDS (Prevention)-Room C-128, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland</aff><aff id="A5"><label>5</label> Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</aff><aff id="A6"><label>6</label> Global AIDS Program, BOTUSA Project, PO Box 90, Gaborone, Botswana</aff><author-notes><corresp id="COR1">Correspondence to: T M Painter</corresp></author-notes><pub-date pub-type="ppub"><day>4</day><month>9</month><year>2004</year></pub-date><pub-date pub-type="epub"><day>2</day><month>9</month><year>2004</year></pub-date><volume>329</volume><volume-id pub-id-type="other">329</volume-id><volume-id pub-id-type="other">329</volume-id><issue>7465</issue><issue-id pub-id-type="other">bmj;329/7465</issue-id><issue-id pub-id-type="other">7465</issue-id><issue-id pub-id-type="other">329/7465</issue-id><fpage>543</fpage><history><date date-type="accepted"><day>6</day><month>7</month><year>2004</year></date></history><permissions><copyright-statement>© 2004 BMJ Publishing Group Ltd.</copyright-statement><copyright-year>2004</copyright-year></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="bmj-329-543.pdf"></self-uri><abstract><title>Abstract</title><p><bold>Objective</bold> To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis.</p><p><bold>Design</bold> Qualitative interview study.</p><p><bold>Setting</bold> A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Côte d'Ivoire.</p><p><bold>Participants</bold> Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis.</p><p><bold>Results</bold> Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors.</p><p><bold>Conclusions</bold> Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.</p></abstract><counts><page-count count="1"></page-count></counts></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study</title></titleInfo><name type="personal"><namePart type="given">Thomas M</namePart><namePart type="family">Painter</namePart><affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</affiliation><affiliation>Correspondence to: T M Painter</affiliation><description>behavioral scientist</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kassamba L</namePart><namePart type="family">Diaby</namePart><affiliation>Projet RETRO-CI, US Embassy/CDC-HIV, 01 BP 1712 Abidjan 01, Côte d'Ivoire</affiliation><description>medical supervisor</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Danielle M</namePart><namePart type="family">Matia</namePart><affiliation>266th Pl SE, Sammamish, Washington 98075, USA</affiliation><description>program officer</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Lillian S</namePart><namePart type="family">Lin</namePart><affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</affiliation><description>acting leader, statistics team</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Toussaint S</namePart><namePart type="family">Sibailly</namePart><affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</affiliation><description>technical advisor</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Moïse K</namePart><namePart type="family">Kouassi</namePart><affiliation>Centers for Disease Control and Prevention, Global AIDS Program, Rwanda, US Embassy, BP 28, Kigali, Rwanda</affiliation><description>manager, local area network</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ehounou R</namePart><namePart type="family">Ekpini</namePart><affiliation>Department of HIV/AIDS (Prevention)-Room C-128, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland</affiliation><description>medical officer</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Thierry H</namePart><namePart type="family">Roels</namePart><affiliation>Global AIDS Program, BOTUSA Project, PO Box 90, Gaborone, Botswana</affiliation><description>associate director</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Stefan Z</namePart><namePart type="family">Wiktor</namePart><affiliation>Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mail stop E-37, Atlanta, Georgia 30333, USA</affiliation><description>chief, Surveillance and Infrastructure Development Branch, Global AIDS Program</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>British Medical Journal Publishing Group</publisher><dateIssued encoding="w3cdtf">2004-09-04</dateIssued><dateCreated encoding="w3cdtf">2004-09-02</dateCreated><copyrightDate encoding="w3cdtf">2004</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Côte d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.</abstract><note type="author-notes">Correspondence to: T M Painter</note><relatedItem type="host"><titleInfo><title>BMJ</title></titleInfo><titleInfo type="abbreviated"><title>BMJ</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>hwp-journal-coll</genre><topic>Infectious diseases</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Immunology (including allergy)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Pregnancy</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Reproductive medicine</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Child health</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Sexual health</topic></subject><identifier type="ISSN">0959-8138</identifier><identifier type="eISSN">1468-5833</identifier><identifier type="PublisherID">BMJ</identifier><identifier type="PublisherID-hwp">bmj</identifier><identifier type="PublisherID-nlm-ta">BMJ</identifier><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>329</number></detail><detail type="issue"><caption>no.</caption><number>7465</number></detail><extent unit="pages"><start>543</start><total>1</total></extent></part></relatedItem><identifier type="istex">7880DBA1A34EF8B38B616FD5097E4C522B2BB60E</identifier><identifier type="ark">ark:/67375/NVC-RB7R9HHS-X</identifier><identifier type="DOI">10.1136/bmj.329.7465.543</identifier><identifier type="href">bmj-329-543.pdf</identifier><identifier type="ArticleID">bmj.329.7465.543</identifier><identifier type="PMID">15345628</identifier><identifier type="local">bmj;329/7465/543</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2004 BMJ Publishing Group Ltd.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</recordContentSource><recordOrigin>© 2004 BMJ Publishing Group Ltd.</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/document/7880DBA1A34EF8B38B616FD5097E4C522B2BB60E/metadata/json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002733 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002733 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:7880DBA1A34EF8B38B616FD5097E4C522B2BB60E
|texte= Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study
}}
| This area was generated with Dilib version V0.6.32. |  |